Sign inJoin waitlistJoin the waitlist

GP

Gregory Pennock

Hematology & Oncology

Credentials: · · ·

History

Hematology and Medical Oncology
University of Pittsburgh
Allegheny General Hospital
University TX

Research

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
The Lancet · 2016 · 464 citations
The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment
Review · The Oncologist · 2015 · First of 2 authors · Corresponding · 182 citations
An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue…
European Journal of Cancer · 2013 · 82 citations

Anthony Elias
2 papers
Douglas Adkins
2 papers
Adil Daud
1 paper
Alberto Pappo
1 paper
Alfredo Quinones-Hinojosa
1 paper
Amy Qin
1 paper
Andrea Apolo
1 paper
AT
Anthony Tolcher
1 paper
Bartosz Chmielowski
1 paper
Brad Zacharia
1 paper
Brenda Weigel
1 paper
Brian Gill
1 paper